(Q36238699)

13 August 2017

1 reference

title

MUC1 as a target antigen for cancer immunotherapy (English)

1 reference

13 August 2017

1 reference

Bruce Acres

1

1 reference

13 August 2017

Jean-Marc Limacher

series ordinal

2

1 reference

13 August 2017

publication date

1 August 2005

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

493-502

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Differential regulation of membrane-associated mucins in the human ocular surface epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Is episialin/MUC1 involved in breast cancer progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Is MUC1 polymorphism associated with female infertility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

MUC1 mucin-mediated regulation of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Lack of evidence for an immunosuppressive role for MUC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Regulated expression of MUC1 epithelial antigen in erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

MUC1 and the immunobiology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Gene-based vaccines and immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.493

21 January 2018

Identifiers

DOI

10.1586/14760584.4.4.493

1 reference

13 August 2017

1 reference